Shares of Dr Reddy's Laboratories fell by 5% as the company's third-quarter profit rise failed to impress investors. The ...

Dr Reddy’s Laboratories on Thursday said its consolidated net profit increased 2 per cent to Rs 1,413 crore in the third ...

(Reuters) -Shares of Dr Reddy's Laboratories dropped 6% on Friday and were on track for their worst session in nearly nine ...

Dr Reddy’s Laboratories share price declined more than 6% in the morning trades on Friday post Q3 results that were announced after the market hours of Thursday ...

Dr. Reddy's stock falls on Q3 fiscal 2025 results, wherein earnings match estimates but revenues beat the same.

Indian generic drugmaker Dr Reddys Laboratories expressed optimism about the Donald Trump administration on Thursday, citing ...

Donald Trump's swearing-in ceremony, Davos and Q3 earnings are among the major events that took place this week.

At close, Sensex fell 0.43 per cent at 76,190.46, while the Nifty declined 0.49 per cent, ending at 23,092.20. BSE MidCap and ...

Shares of Dr Reddy’s Laboratories on Friday ended 5 per cent lower after the company's third-quarter earnings failed to cheer ...

Market experts analyze Friday's downturn, highlighting concerns over corporate earnings, sectoral performance, and market ...

Emcure Pharmaceuticals has opened its new formulation research and development (R&D) centre in Ahmedabad, in the Indian state ...

Downside momentum continued in the Indian stock market on Friday after a slight upside bounce on two previous sessions. The ...